The role of GRK6 in animal models of Parkinson's disease and L-DOPA treatment.
The role of GRK6 in animal models of Parkinson's disease and L-DOPA treatment.
复制标题
DOI:
10.1038/srep00301
复制
发表时间:
2012
影响因子:
4.6
通讯作者:
Gainetdinov, Raul R.
中科院分区:
文献类型:
--
作者:
Manago, Francesca;Espinoza, Stefano;Salahpour, Ali;Sotnikova, Tatyana D.;Caron, Marc G.;Premont, Richard T.;Gainetdinov, Raul R.
G protein-coupled Receptor Kinase 6 (GRK6) belongs to a family of kinases that phosphorylate GPCRs. GRK6 levels were found to be altered in Parkinson's Disease (PD) and D2 dopamine receptors are supersensitive in mice lacking GRK6 (GRK6-KO mice). To understand how GRK6 modulates the behavioral manifestations of dopamine deficiency and responses to L-DOPA, we used three approaches to model PD in GRK6-KO mice: 1) the cataleptic response to haloperidol; 2) introducing GRK6 mutation to an acute model of absolute dopamine deficiency, DDD mice; 3) hemiparkinsonian 6-OHDA model. Furthermore, dopamine-related striatal signaling was analyzed by assessing the phosphorylation of AKT/GSK3β and ERK1/2. GRK6 deficiency reduced cataleptic behavior, potentiated the acute effect of L-DOPA in DDD mice, reduced rotational behavior in hemi-parkinsonian mice, and reduced abnormal involuntary movements induced by chronic L-DOPA. These data indicate that approaches to regulate GRK6 activity could be useful in modulating both therapeutic and side-effects of L-DOPA.
登录
查看更多内容
影响因子:
6.1
作者:
Bezard, E;Gross, CE;Gurevich, EV
通讯作者:
Gurevich, EV
影响因子:
4.8
作者:
Ghisi, Valentina;Ramsey, Amy J.;Salahpour, Ali
通讯作者:
Salahpour, Ali
影响因子:
30.8
作者:
Emamian, ES;Hall, D;Gogos, JA
通讯作者:
Gogos, JA
影响因子:
5
作者:
Boulay, D;Depoortere, R;Perrault, G
通讯作者:
Perrault, G
影响因子:
82.9
作者:
Bézard, E;Ferry, S;Sokoloff, P
通讯作者:
Sokoloff, P